期刊文献+

短期与长期激素替代疗法对绝经后妇女血脂的影响 被引量:6

The effects of short-and long-term hormone replacement therapy on serum lipids in the postmenopausal women
在线阅读 下载PDF
导出
摘要 目的 观察绝经后妇女短期 (3个月 )与长期 (9~ 2 9年 )应用激素替代疗法 (HRT)对血脂的影响。 方法  9例绝经后妇女短期单服戊酸雌二醇 (E2 )替代疗法 (ERT) 1mg/d与 30例用戊酸E2 1mg/d加醋酸甲羟孕酮 (MPA) 2mg/d的HRT。在治疗前及治疗 3个月后 ,检测血清雌二醇 (E2 )、卵泡刺激素 (FSH)和血脂水平。另外 ,对 11例绝经后妇女经多种性激素替代疗法 (mHRT) 9~ 2 9年者 ,同样检测上述各项指标及血清一氧化氮 (NO)和血管紧张素II(AngII)的水平。 结果  (1)单服戊酸E2 (ERT)组及联合用戊酸E2 +MPA组 (HRT或mHRT)均使绝经后妇女的血清E2 达到正常水平 ,FSH水平下降 ,两种HRT后的水平均与对照组有显著差异 (P <0 .0 5 )。 (2 ) 11例用mHRT疗法 9~ 2 9年的受试者 ,NO和AngII水平与对照组比较 ,均未见明显变化 ;血载脂蛋白A1(ApoA1)从 (1.4 2± 0 .2 1)g/L升至 (1.70± 0 .38)g/L ,两者有显著差异 (P <0 .0 5 ) ,而脂蛋白 (a) [Lp(a) ]从 (0 .2 4± 0 .13)g/L降至 (0 .13± 0 .10 )g/L也有显著差异 (P <0 .0 5 ) ,其余各种血脂水平与对照组比较未见显著差异 (P >0 .0 5 )。 结论 经 3个月ERT后 ,可使血浆胆固醇水平明显下降。经过 9~ 2 9年mHRT后 ,可使血脂ApoA1水平升高 ,Lp(a)水平降低。这种血脂? Objective: To study the effects of different hormone replacement therapies with short and long term of use on serum lipids in postmenopausal women.Methods:Serum levels of 17 β-estradiol (E2),follicle stimulating hormone (FSH) and serum lipid levels in postmenopausal women were determined before and after short-term (3 months) use of estradiol valevate 1 mg/d (ERT) ( n =9) or estradiol valevate 1 mg/d plus medroxyprogesterone acetate (MPA) 2 mg/d (HRT) ( n =30). Same tests,as well as the levels of angiotensin II (Ang II) and nitric oxide (NO),were done in 11 postmenopausal women with the long term (9~29 years) use of multiple replacement therapies (mHRT).Results:(1) The concentration of E2 was increased to normal levels while FSH decreased in the postmenopausal women using ERT or HRT or mHRT. Both showed significant changes ( P <0.05) in comparison with normal control. (2) In 11 postmenopausal women treated with mHRT for 9~29 years,the levels of serum apoliprotein A1 (Apo A1) were increased from (1.42±0.21) g/L to (1.70±0.38) g/L,and the levels of serum lipoprotein (a) [Lp(a)] decreased from (0.24±0.13) g/L to (0.13±0.10) g/L. Both showed significant changes ( P <0.05). The levels of serum nitric oxide and Ang II did not change when compared with the normal control. (3) Except for the decreased serum levels of cholesterol in the postmenopausal women with ERT for 3 months,the levels of other lipids in the women with ERT or HRT were not found to be different from those before HRT.
机构地区 中国医学科学院
出处 《生殖医学杂志》 CAS 2004年第3期131-134,共4页 Journal of Reproductive Medicine
基金 科技部 1999年度攀登-特别支持费资助 (国科基字 [1999] 0 45 )
关键词 激素替代疗法 血脂 戊酸雌二醇 醋酸甲羟孕酮 绝经期 Hormone replacement therapy Serum lipid Estradiol valevate Medroxyprogesterone acetate Menopause
  • 相关文献

参考文献10

  • 1聂敏,孙梅励,何方方,孙琦,葛秦生.雌激素对内皮细胞释放一氧化氮的作用[J].中国医学科学院学报,2001,23(5):485-489. 被引量:17
  • 2郑欣,何方方,聂敏,孙梅励,葛秦生.性激素对绝经后妇女血一氧化氮、血管紧张素Ⅱ水平的影响[J].中国医学科学院学报,2002,24(6):625-638. 被引量:8
  • 3Ossewaarde ME,Dallinga Thie GM,Bots ML,et al. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women : results from a randomized trial [J]. Eur J Clin Invest, 2003,33 (5):376-382.
  • 4Writing group for the women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial [J]. J Am Med Assoc, 2002, 288(3)
  • 5Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence [J]. Am J Cardiol, 2002, 90 (1A): 22F-25F.
  • 6Schneider HPG. The view of the international menopause society on the Women's Health Initiative[J]. Climacteric, 2002, 5(3): 211-216.
  • 7Knopp RH. Risk factors for coronary artery disease in women [J]. Am J Cardiol, 2002, 89[Suppl]: 28E-35E.
  • 8Kuller LH. Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative [J]. Arterioscler Thromb Vasc Biol, 2003, 23(1):11-16.
  • 9Mendelsohn ME. Protective effects of estrogen on the cardiovascular system [J]. Am J Cardiol, 2002, 89[Suppl]: 12E-18E.
  • 10Humphries Kh,Gill S .Risks and benefits of hormone re- placement therapy : the evidence speaks [J].CMAJ, 2003,168 (8) :1001-1010.

二级参考文献10

  • 1Schneider HPG. The view of the international menopause society on the women's health initiative. Climacteric, 2002,5:211-216
  • 2Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med, 1999,340:1801-1811
  • 3Gallagher PE, Li P, Lenhart JR, et al. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension, 1999,33:323-328
  • 4Umeda M, Ichikawa S, Kanda T, et al. Hormone replacement therapy increase plasma of angiotensin Ⅱ in postmenopausal hypertensive women. Am J Hypertens, 2001, 14 (3) :206-211
  • 5Imthurn B, Rosselli M, Jaeger AW, et al. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. JCE&M, 1997, 82:388-394
  • 6Kawano H, Motoyama T, Hirai N, et al. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol, 2001,87:238-240
  • 7Sitruk-ware R. Progestins and cardiovascular risk markers. Steroids, 2000, 65:651-658
  • 8Austin CE. Chronic and acute effects of oestrogens on vascular contractility. J Hyptertens, 2000, 18:1365-1378
  • 9杜志军,孙梅励,王柏生,祁元明,葛秦生.性激素对血管作用的研究[J].中国医学科学院学报,1999,21(4):282-287. 被引量:22
  • 10聂敏,孙梅励,何方方,孙琦,葛秦生.雌激素对内皮细胞释放一氧化氮的作用[J].中国医学科学院学报,2001,23(5):485-489. 被引量:17

共引文献19

同被引文献46

  • 1葛秦生.绝经后低剂量激素替代疗法的临床应用[J].生殖医学杂志,2004,13(3):129-130. 被引量:10
  • 2程国钧,刘建立.绝经后妇女雌激素替代治疗[J].中华妇产科杂志,1995,30(2):123-127. 被引量:150
  • 3聂敏,孙梅励,宋爱羚,葛秦生.长期小剂量性激素疗法对绝经后妇女血压及血管活性因子的作用[J].生殖医学杂志,2005,14(6):321-324. 被引量:2
  • 4王文清,宁波,王新宴,谈维洁,李玲,徐丽梅,李丰.C反应蛋白与冠心病病变程度的相关性[J].心脏杂志,2006,18(3):323-325. 被引量:18
  • 5Mikkola TS,Anthony MS,Clarkson TB,et al.Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugate estrogens [J].Metabolism,2002;51:523-30.
  • 6Cagnacci A,Mallus E,Tuveri F,et al.Effect of tibolone on glucose and lipid metabolism in postmenopausal women[J].J Clin Endocrinol Metab,1997;82:251-3.
  • 7Lindheim SR.Comparison of estimates of insulin sensitivity in pre-and postmenonpausal women using the insulin tolerance test and the FSIGT [J].J Soc Gynecol Invest,1994;1:150.
  • 8Bjarnason NH,Bjarnason K,Haarbo J,et al.Tibolone:influence onmarkers of cardiovascular disease[J].J Clin Endocrinol Metab,1997;82(6):1752-6.
  • 9Mueck AO,Lippert C,Seeger H,et al.Effects of tibolone on human breast cancer cells and human vascular coronary cells[J].Arch Gynecol Obstet,2003;267(3):139-44.
  • 10Koh KK,Ahn JY,Jin DK,et al.Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women:a randomized,double-blind,placebo-controlled,crossover study[J].Arterioscler Thromb Vasc Biol,2003;23(10):1889-94.

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部